about
Evaluation of intra-lesional corticosteroids in the treatment of peri-ocular haemangioma of infancy: still an alternative besides propranolol.Educational paper: therapy of infantile haemangioma--history and current state (part II).Scoring the proliferative activity of haemangioma of infancy: the Haemangioma Activity Score (HAS).Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.Scoring the proliferative activity of haemangioma of infancy: to HAS or not to HAS? Reply from author.Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol.Correlation between Objective SCORAD and Three-Item Severity Score used by physicians and Objective PO-SCORAD used by parents/patients in children with atopic dermatitis.Support for the hypoxia theory in the pathogenesis of infantile haemangioma.Treatment of small superficial haemangioma with timolol 0.5% ophthalmic solution: a series of 20 casesTreating hemangioma of infancy with beta-blockers: is there really a risk of hypotension?Do we have to check glucose in patients with haemangioma of infancy treated with beta-blockers?Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS)Multiple cutaneous infantile haemangiomas and the risk of internal haemangiomaScoring systems for infantile hemangioma: the Hemangioma Activity Score versus the Hemangioma Activity and Severity IndexThe proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trialIntractable vascular autonomic dysregulation (Harlequin phenomenon) in two brothers: another indication for propranolol?Validation of Patient-Reported Outcomes Information System Sleep Disturbance and Sleep-Related Impairment in adults with atopic dermatitisComment on "Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas"Minimizing differences in treatment: expert- and evidence-based guidelines for propranolol treatment of infantile haemangiomas in the U.K. and beyondValidation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients
P50
Q35851345-30440456-6129-4FCB-8C64-DDB65FA57A51Q38245341-D525759D-4D47-40A4-94F0-13FCC634FBFAQ39705851-4EDAD6D4-A9FB-48D6-B173-62414C3CC374Q40424734-1CF1F6D5-488A-4756-BE3D-6D98FBF9ABFBQ44834746-6890D652-D3EA-4B1C-9086-6FD544BE77A4Q46429879-0055142A-56E1-4006-B87C-32AA7DD35327Q48050345-21C7FD8A-8E43-4638-95C4-537166CC553EQ51674697-A03D3E1C-B125-4BC3-A683-2742CAB2781CQ83012449-E9AA254E-2C9E-4078-AC01-9397DA4CE75AQ84572607-E2903BC6-E2E5-47BA-8DB9-B75C2A938BA9Q84612350-99F3731F-9E8D-4B3C-B169-77C458055A25Q85617492-A666AC1A-F31C-44E7-8A93-94F20D967A49Q86164782-B6C3E088-2D01-41A0-8916-1A95FEF87EC1Q87284619-7AD19FA6-AF05-4D87-962E-863F0C72DB4EQ87607609-61DCAF35-E1B2-458F-A675-E95A612B60DFQ87718533-C4A988A7-ADF7-4BAD-AE42-F546E5209953Q89524189-C22E81D6-6624-40D7-87EB-40A1833FD0FBQ90142426-502B3DCF-FBC1-46A1-8FE1-353BDAF77806Q91483716-F96FC2D3-8F59-4F6B-9580-C29E49CCAAD5Q91921920-B95A9270-3E15-4FFD-9F7D-22B8FC6B90CF
P50
description
investigador
@es
researcher
@en
name
S R Janmohamed
@en
type
label
S R Janmohamed
@en
prefLabel
S R Janmohamed
@en
P31
P496
0000-0002-8700-480X